R&F Capital Advisors’s VivoSim Labs VIVS Stock Holding History

R&F Capital Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-104	Closed	-$84K	–	840
2016 Q4	$84K	Buy	+104	New	+$82.5K	0.03%	455

Other funds holding VIVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

R&F Capital Advisors's VIVS Position: Q1 2017 in Review

R&F Capital Advisors sold out of VivoSim Labs (VIVS) in Q1 2017, closing a stake of 104 shares — an estimated $84K sold.

R&F Capital Advisors first reported a position in VIVS in Q4 2016 and held it in 1 quarter. The position peaked at $84K in Q4 2016. 115 funds tracked by Wall St. Rank hold VIVS as of Q1 2017.

R&F Capital Advisors reported no remaining VivoSim Labs position as of Q1 2017 after selling out during the quarter.
R&F Capital Advisors sold 104 VivoSim Labs shares in Q1 2017, an estimated $84K.
R&F Capital Advisors first reported a position in VivoSim Labs in Q4 2016 and held it in 1 quarter.
R&F Capital Advisors's VivoSim Labs position peaked at $84K in Q4 2016.
115 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.